Introduction {#s1}
============

The role of exercise in regulating bone health is still not well understood. However healthy bone is typically related to increased mechanical loading [@pone.0024841-Goulet1]. The magnitude of the strain could prevent and treat low bone mineral density (BMD) [@pone.0024841-Gass1], [@pone.0024841-Kohrt1] or increase the acquisition of bone mass during growth [@pone.0024841-VicenteRodriguez1].

Cycling can be considered a healthy sport because it improves physical fitness and prevents fat accumulation [@pone.0024841-deGeus1], [@pone.0024841-Matthews1]. Adolescence is a sensitive phase for the acquisition of bone mass [@pone.0024841-Duncan1], [@pone.0024841-Rizzoli1]. Around 90% of bone mass is present at the end of the skeletal maturation phase [@pone.0024841-Slemenda1]. Many professional and master cyclists can be classified as osteopenic [@pone.0024841-Medelli1], [@pone.0024841-Nichols1], [@pone.0024841-Rector1]. Professional road cyclists have significantly lower bone mineral density (BMD) than the non-active population [@pone.0024841-Medelli1]. It is assumed that this non weight-bearing activity an insufficient stimulus to generate osteogenesis in clinically relevant bone sites [@pone.0024841-Rector1], [@pone.0024841-Warner1].

Rico et al. [@pone.0024841-Rico1] did not find differences in the BMC in total or any regional site between adolescent cyclists and age-matched sedentary controls. Similarly, Duncan et al. [@pone.0024841-Duncan1] observed that female adolescent cyclists had similar BMD values for the whole body, lumbar, femoral neck, legs and arms than non-athlete controls. These researchers also found no differences among groups in mid-femur for the BMC and volumetric bone mineral density (vBMD) measured by computed tomography [@pone.0024841-Duncan2]. However, when these adolescent cyclists were compared with a group of runners, female cyclists showed significant lower values for BMD for the whole body, femoral neck and legs, and lower bone strength [@pone.0024841-Duncan2].

We hypothesized that cycling during adolescence is associated with lower bone mass acquisition compared a healthy adolescent population. Therefore the main aim of this investigation was to describe the bone status in adolescent cyclists compared to a healthy age-matched group. A secondary aim was to analyse the effect of years of cycling practice on the on the acquisition of bone mass.

Materials and Methods {#s2}
=====================

Ethics statement {#s2a}
----------------

Written informed consent was obtained from parents and adolescents [@pone.0024841-Beghin1]. The study was performed following the ethical guidelines of the Declaration of Helsinki 1961 (revision of Edinburgh 2000). The protocol study was approved by the Ethics Committee of Clinical Research from the Government of Aragón (CEICA; Spain).

Subjects {#s2b}
--------

Forty-four healthy male adolescents agreed to participate in the study ([Table 1](#pone-0024841-t001){ref-type="table"}). To be included, subjects had to be bellow 21 years of age, healthy, without any chronic disease and free of musculoskeletal conditions, bone fractures, medications or habits affecting bone development. Twenty-two adolescent male road cyclists (CY) were recruited from different cycling teams from Aragon (Spain). All cyclists were regular participants in regional competitions, and had been participating in training sessions and competitions a mean 10 hours per week (h/week) for a minimum of 2 and a maximum of 7 years prior to the study. Twenty-two controls (CG), physically-active boys, were recruited among high school and physical education course university students. Control subjects were enrolled in recreational sports (rugby, tennis, handball, soccer) 2 h a week with occasional match at the weekend but none cycled more than 1 h per week. Cyclists and controls were divided into two subgroups, younger (\<17 yr: n = 24, 11 cyclists and 13 controls) and older (\>17 yr: n = 20, 11 cyclists and 9 controls), ([Table 2](#pone-0024841-t002){ref-type="table"}). Subjects were asked to answer a medical and physical activity questionnaire and the parents gave additional information regarding physical activity, medical information such as past injuries, medication, known diseases and smoking habits.

10.1371/journal.pone.0024841.t001

###### Subject characteristics.

![](pone.0024841.t001){#pone-0024841-t001-1}

                                       Controls (n = 22)   Cyclists (n = 22)                     
  ----------------------------------- ------------------- ------------------- ------ ------- --- --------------------------------------
  Age (years)                                16.7                  ±           2.1    16.9    ±                   1.9
  Height (cm)                                176.1                 ±           8.9    173.2   ±                   6.7
  Body mass (kg)                             74.4                  ±           16.8   61.3    ±   7.7[\*](#nt102){ref-type="table-fn"}
  Body fat mass (kg)                         15.6                  ±           8.7     8.8    ±   3.0[\*](#nt102){ref-type="table-fn"}
  \% total body fat                          21.8                  ±           8.5    15.7    ±   4.5[\*](#nt102){ref-type="table-fn"}
  Total lean mass (kg)                       56.9                  ±           10.7   50.7    ±   6.6[\*](#nt102){ref-type="table-fn"}
  VO~2peak~ (mL kg^−1^ min^−1^)              41.7                  ±           9.0    56.6    ±   9.3[\*](#nt102){ref-type="table-fn"}
  Years of cycling training (yr)                                                       3.7    ±                   1.9
  Hours of cycling training (h/sem)                                                   10.2    ±                   1.8

Values are presented as mean ± SD.

\*P\<0.05 compared to controls. Peak oxygen uptake (VO~2~max).

10.1371/journal.pone.0024841.t002

###### Subject characteristics.

![](pone.0024841.t002){#pone-0024841-t002-2}

                                       Controls   Cyclists                                                                                            
  ----------------------------------- ---------- ---------- ------ ------- --- ------ ------- --- --------------------------------------- ------- --- --------------------------------------
  Age (years)                            15.2        ±       1.2    18.7    ±   1.2    15.5    ±                    0.9                    18.4    ±                   1.4
  Height (cm)                           173.3        ±       9.8    180.2   ±   5.7    171.1   ±                    5.9                    175.3   ±                   7.0
  Body mass (kg)                         72.7        ±       18.4   76.9    ±   14.9   56.9    ±   5.1[\$](#nt105){ref-type="table-fn"}    65.6    ±                   7.8
  Body fat mass (kg)                      17         ±       8.8     16     ±   9.4     9.4    ±   3.5[\$](#nt105){ref-type="table-fn"}    10.1    ±                   2.6
  \% total body fat                      22.9        ±       8.4    20.1    ±   7.5    16.6    ±                    5.6                    15.5    ±                   2.2
  Total lean mass (kg)                   54.9        ±       12.6   59.8    ±   6.8    46.8    ±                    5.1                    54.6    ±                   5.5
  VO~2peak~ (mL kg^−1^ min^−1^)          40.2        ±       9.5    43.5    ±   8.6    55.2    ±   11.7[\$](#nt105){ref-type="table-fn"}   57.9    ±   6.4[\*](#nt104){ref-type="table-fn"}
  Years of cycling training (yr)                                                        2.7    ±                    1.3                     4.4    ±   1.9[λ](#nt106){ref-type="table-fn"}
  Hours of cycling training (h/sem)                                                     8.6    ±                    1.0                    11.4    ±   1.3[λ](#nt106){ref-type="table-fn"}

Values are presented as mean ± SD.

\*P\<0.05 compared to control group ≥17 yr.

P\<0.05 compared to control group \<17 yr.

P\<0.05 compared to Cyclists \<17 yr.

Peak oxygen uptake (VO~2~max).

Cardiorespiratory test {#s2c}
----------------------

Cardiorespiratory tests were performed at the same time of the day (09∶00--13∶00 h) on an electrically braked cycle-ergometer (Ergoselect 200 K, Ergoline; Bitz, Alemania). Subjects refrained from performing physical activity during the 24 h-period before the tests. After a warm-up period of 3-min with no load, power output was increased from an initial value of 30 W with 30 W increments every minute. Subjects maintained pedal cadence within the range of 60--80 rev·min^−1^. The cadence monitor was placed in view of the subject during each test and a designated investigator ensured that they maintained the required pedalling cadence throughout the duration of the test. The tests were terminated upon volitional exhaustion of the subjects and/or when cadence could not be maintained at a minimum of 60 rev·min^−1^. Peak oxygen consumption (VO~2peak~) was determined with a breath by breath gas analyzer (Oxycon Pro, Jaeger/Viasys, Germany). The gas analyzer was calibrated with a known gas prior to the first test each day, as recommended by the company. Electrocardiogram (ECG) was recorded by heart rate, utilizing a 12-lead system at rest, during the whole test and the first 3 minutes of recovery.

Bone, lean and fat mass {#s2d}
-----------------------

Subjects were scanned in order to obtain bone measurements of the whole body, pelvis, hip, lumbar spine, head and average of arms and legs. The bone mass and lean mass \[body mass -- (fat mass + bone mass)\] were measured using DXA (paediatric version of the software QDR-Explorer, Hologic Corp., Software version 12.4, Waltham, MA, USA). DXA equipment was calibrated using a lumbar spine phantom as recommended by the manufacturer. Subjects were scanned in supine position and the scans were performed at high resolution [@pone.0024841-Calbet1]. Lean mass (g), fat mass (g), total area (cm^2^) and BMC (g) were calculated from total and regional analysis of the whole body scan. BMD (g · cm^−2^) was calculated using the formula BMD = BMC area^−2^. The regional analysis (upper and lower extremities and pelvic region) was performed as described elsewhere [@pone.0024841-Calbet1]. Also, examinations were conducted to estimate bone mass at the lumbar spine (L1--L4) and hip regions as previously described [@pone.0024841-VicenteRodriguez2]. Two additional examinations were conducted to estimate bone mass at the lumbar spine (L1--L4) and proximal region of the femur (hip and femoral neck). Volumetric BMD (vBMD) was estimated for the lumbar spine and femoral neck using simple geometric cylindrical models [@pone.0024841-Gravholt1]. Bone mineral apparent density (BMAD) was calculated as previously described [@pone.0024841-Katzman1], using the formula whole body BMAD = BMC/(area^2^/body height).

Statistics {#s2e}
----------

As descriptive statistics, mean and standard deviation (SD) are given for raw data bone mass related variables and mean and standard error for bone mass adjusted results. Normality of data distribution was evaluated with Kolmogorov-Smirnov test.

To determine differences between age-groups in bone mass, one-way ANOVA with Bonferroni post hoc was applied. For adjusted results, one-way analysis of covariance (ANCOVA) with Bonferroni post hoc was used, including as covariates: body size (height) and whole body lean mass. Effect size statistics using Cohen\'s *d* (standardized mean difference) were calculated [@pone.0024841-Nakagawa1]. Taking into account the cut-offs established by Cohen, the effect size can be small (∼0.2), medium (∼0.5) or large (∼0.8). SPSS version 15.0 was used for the analysis. The probability value for the significance level was fixed at 0.05.

Results {#s3}
=======

[Table 1](#pone-0024841-t001){ref-type="table"} and [Table 2](#pone-0024841-t002){ref-type="table"} summarize the descriptive characteristics of the participants. Cyclists and control groups were comparable in age and height. Cyclists had significantly lower body mass, total lean mass, body fat percentage, total body fat and BMI (all, P\<0.01). VO~2peak~ was higher in cyclists than in controls (P\<0.01).

Raw data for bone related variables is presented in [Table 3](#pone-0024841-t003){ref-type="table"}. In general, lower BMC, BMD and bone area was observed in cyclists compared to controls (P\<0.05, [Table 3](#pone-0024841-t003){ref-type="table"}). Bone values adjusted for the combined influence of height and total lean mass are presented in [table 4](#pone-0024841-t004){ref-type="table"}. Compared to controls, cyclists had lower BMC for the whole-body, pelvis, femoral neck and legs (P\<0.01). BMD at the legs, pelvis, total hip and in the trochanter and inter-trochanteric subregion was lower in cyclists than in controls (P\<0.01). Cyclists had lower bone area than controls at the whole-body, legs and femoral neck site (P\<0.01). Total hip area was greater in cyclists than in controls (P\<0.01).

10.1371/journal.pone.0024841.t003

###### Bone mineral content (BMC), density (BMD) and area in control and cyclists group.

![](pone.0024841.t003){#pone-0024841-t003-3}

                       Controls   Cyclists                                  
  ------------------- ---------- ---------- -------- --------- --- -------- -------
  *BMC (g)*                                                                 
  Whole body            2103.4       ±       461.6    1665.3    ±   318.3    0.001
  Pelvis                312.7        ±        87.1     233.1    ±    48.8    0.001
  Hip                    41.6        ±        9.3      36.6     ±    6.0     0.041
  Trochanter             10.2        ±        2.5       8.4     ±    1.7     0.007
  Inter- trochanter      26.0        ±        6.6      23.6     ±    4.1     0.158
  Femoral neck           5.3         ±        0.9       4.5     ±    0.7     0.030
  Lumbar spine           64.4        ±        16.1     53.3     ±    11.4    0.011
  Average arms          167.0        ±        41.1     140.0    ±    33.4    0.022
  Average legs          535.6        ±       108.3     419.5    ±    77.9    0.001
  Head                  491.3        ±        97.9     465.1    ±   109.1    0.405
  *BMD (g cm^−2^)*                                                          
  Whole body            1.061        ±       0.115     0.933    ±   0.084    0.001
  Pelvis                1.243        ±       0.202     0.998    ±   0.115    0.001
  Hip                   1.072        ±       0.132     0.949    ±   0.088    0.001
  Trochanter            0.877        ±       0.095     0.741    ±   0.086    0.001
  Inter-trochanter      1.201        ±       0.164     1.073    ±   0.941    0.001
  Femoral-neck          0.985        ±       0.132     0.873    ±   0.112    0.004
  Lumbar spine          0.998        ±       0.157     0.875    ±   0.111    0.005
  Average arms          0.762        ±       0.078     0.717    ±   0.617    0.001
  Average legs          1.325        ±       0.144     1.161    ±   0.119    0.001
  Head                  2.030        ±       0.335     1.965    ±   0.383    0.553
  *vBMD (g·cm^−3^)*                                                         
  Femoral neck          0.354        ±       0.051     0.324    ±   0.044    0.050
  Lumbar spine          0.274        ±       0.032     0.257    ±   0.029    0.087
  BMAD                  0.130        ±       0.171     0.091    ±   0.006    0.291
  *Area (cm^−2^)*                                                           
  Whole body           1963.43       ±       258.89   1771.89   ±   181.99   0.001
  Pelvis                248.03       ±       43.52     231.7    ±   26.26    0.139
  Hip                   38.44        ±        5.80     38.37    ±    3.77    0.160
  Trochanter            11.57        ±        1.88     11.27    ±    1.19    0.529
  Inter-trochanter      21.52        ±        4.25     21.96    ±    2.80    0.688
  Femoral-neck           5.35        ±        0.44     5.14     ±    0.37    0.091
  Lumbar spine          63.90        ±        9.11     60.48    ±    6.58    0.959
  Average arms          216.82       ±       36.79    193.12    ±   30.14    0.024
  Average legs          401.7        ±       50.29    359.31    ±   33.79    0.002
  Head                  240.92       ±       14.20    235.52    ±   14.18    0.213

Values as mean and SD.

P\<0.05 compared with control group. Volumetric bone mineral density (vBMD); bone mineral apparent density (BMAD).

10.1371/journal.pone.0024841.t004

###### Adjusted bone mineral content (BMC), density (BMD) and area in control.

![](pone.0024841.t004){#pone-0024841-t004-4}

                       Controls   Cyclists                               
  ------------------- ---------- ---------- ------- -------- --- ------- -------
  *BMC (g)*                                                              
  Whole body            2438.1       ±       39.3    2287.0   ±   39.3    0.012
  Pelvis                291.2        ±        7.8    254.6    ±    7.8    0.003
  Hip                    39.2        ±        0.9     38.9    ±    0.9    0.777
  Trochanter             9.7         ±        0.3     9.0     ±    0.3    0.135
  Inter-trochanter       24.5        ±        0.7     25.2    ±    0.7    0.533
  Femoral neck           5.1         ±        0.1     4.7     ±    0.1    0.054
  Lumbar spine           60.8        ±        2.1     56.9    ±    2.1    0.200
  Average arms          154.7        ±        3.2    152.3    ±    3.2    0.606
  Average legs          506.1        ±        8.4    449.0    ±    8.4    0.001
  Head                  464.6        ±       15.7    491.9    ±   15.7    0.241
  *BMD (g cm^−2^)*                                                       
  Whole body            1.132        ±       0.016   1.089    ±   0.016   0.065
  Pelvis                1.200        ±       0.026   1.042    ±   0.026   0.001
  Hip                   1.045        ±       0.190   0.976    ±   0.190   0.015
  Trochanter            0.860        ±       0.160   0.760    ±   0.160   0.001
  Inter-trochanter      1.170        ±       0.023   1.104    ±   0.023   0.054
  Femoral neck          0.956        ±       0.200   0.903    ±   0.020   0.082
  Lumbar spine          0.961        ±       0.200   0.912    ±   0.200   0.110
  Average arms          0.742        ±       0.090   0.738    ±   0.090   0.787
  Average legs          1.287        ±       0.018   1.199    ±   0.018   0.002
  Head                  1.940        ±       0.060   2.050    ±   0.060   0.214
  *vBMD (g cm^−3^)*                                                      
  Femoral neck          0.347        ±       0.008   0.331    ±   0.008   0.160
  Lumbar spine          0.268        ±       0.006   0.264    ±   0.006   0.579
  BMAD                  0.127        ±       0.027   0.094    ±   0.027   0.412
  Area (cm^−2^)                                                          
  Whole body           2133.25       ±       15.65   2078.5   ±   15.65   0.021
  Pelvis                238.44       ±       3.97    241.29   ±   3.97    0.626
  Hip                   37.22        ±       0.54    39.59    ±   0.54    0.004
  Trochanter            11.50        ±       0.02    11.80    ±   0.02    0.115
  Inter-trochanter      20.75        ±       0.53    22.73    ±   0.53    0.014
  Femoral neck           5.30        ±       0.06     5.19    ±   0.06    0.249
  Lumbar spine          62.46        ±       1.13    61.92    ±   1.13    0.746
  Average arms          206.34       ±       3.33    203.60   ±   3.33    0.576
  Average legs          390.78       ±       4.98    370.22   ±   4.98    0.007
  Head                  238.12       ±       2.17    238.31   ±   2.17    0.952

Values as mean and SD.

\*P\<0.05 compared to control group. Volumetric bone mineral density (vBMD); bone mineral apparent density (BMAD).

[Table 5](#pone-0024841-t005){ref-type="table"}, [6](#pone-0024841-t006){ref-type="table"} & [7](#pone-0024841-t007){ref-type="table"} summarize raw data for bone based on whether cyclists and controls were younger or older than 17 years. Cyclists under 17 had lower BMC in the arms and legs and lower BMD in the whole body, pelvis, throchanter, arms and legs; and cyclists over 17 had lower BMC in the pelvis, femoral neck and legs, and lower BMD in the pelvis, hip, throchanter, femoral neck and legs (all P\<0.05, [Table 5](#pone-0024841-t005){ref-type="table"}, [6](#pone-0024841-t006){ref-type="table"}). [Table 8](#pone-0024841-t008){ref-type="table"}, [9](#pone-0024841-t009){ref-type="table"} & [10](#pone-0024841-t010){ref-type="table"} present the bone values adjusted by height and total lean mass. When differences between groups were compared by age, cyclists under 17 had 10% lower BMC in the legs and 8% higher total hip area than age-matched controls (P\<0.05). In groups over 17, cyclists had 26.5%, 15.8% and 14.4% lower BMC than controls at the pelvis, femoral neck and legs, respectively (P\<0.05). BMD was lower in cyclists over 17 than in age-matched controls at the pelvis, hip, trochanter, inter-trochanter, femoral neck and legs (the percentages being 24.5, 10.5, 16.2, 7.5, 15.8 and 14.3, respectively, P\<0.05). In addition, cyclists had a vBMD 17.1% lower than controls at the femoral neck (P\<0.05, [Table 9](#pone-0024841-t009){ref-type="table"}).

10.1371/journal.pone.0024841.t005

###### Bone mineral content (BMC), density (BMD) and area in control and cyclist group under 17 (\<17 yr) and equal or over (≥17 yr).

![](pone.0024841.t005){#pone-0024841-t005-5}

                      Controls       Cyclists                                                                         
  ------------------ ---------- --- ---------- -------- --- ------- ------- -------- --- ------- -------- --- ------- -------
  Whole body           2469.0    ±    606.5     2776.5   ±   409.7   0.043   1934.7   ±   285.9   2325.9   ±   436.6   0.213
  Pelvis               286.3     ±     93.1     351.0    ±   64.2    0.077   214.8    ±   46.3    251.4    ±   46.0    0.012
  Hip                   38.2     ±     9.3       46.4    ±    7.5      1      34.4    ±    5.8     38.7    ±    5.8    0.146
  Trochanter            9.6      ±     2.4       11.2    ±    2.5    0.393    8.0     ±    1.5     8.8     ±    1.8    0.101
  Inter-trochanter      23.6     ±     7.0       29.5    ±    4.4    1.000    22.1    ±    4.2     25.2    ±    3.5    0.400
  Femoral neck          5.0      ±     0.8       5.7     ±    0.9    0.287    4.3     ±    0.5     4.7     ±    0.9    0.032
  Lumbar spine          59.2     ±     16.3      72.0    ±   13.1    0.394    49.0    ±    9.8     57.7    ±   11.6    0.114
  Average arms         160.2     ±     47.9     176.9    ±   28.4    0.048   120.2    ±   24.0    159.9    ±   30.8      1
  Average legs         515.0     ±    120.7     565.4    ±   85.0    0.012   390.1    ±   57.6    449.0    ±   86.8    0.043
  Head                 468.0     ±    101.3     525.2    ±   87.0      1     412.7    ±   76.2    517.4    ±   114.8     1

Values as mean and SD. P values calculated with ANOVA.

\*P\<0.05 compared to control group ≥17 yr.

P\<0.05 compared to control group \<17 yr.

10.1371/journal.pone.0024841.t006

###### Bone mineral density (BMD) and volumetric density (vBMD) in control and cyclist group under 17 (\<17 yr) and equal or over (≥17 yr).

![](pone.0024841.t006){#pone-0024841-t006-6}

                       Controls       Cyclists                                                                      
  ------------------- ---------- --- ---------- ------- --- ------- ------- ------- --- ------- ------- --- ------- -------
  Whole body            1.133     ±    0.127     1.215   ±   0.119   0.036   1.002   ±   0.926   1.106   ±   0.097   0.204
  Pelvis                1.183     ±    0.164     1.33    ±   0.229   0.110   0.966   ±   0.109   1.03    ±   0.118   0.001
  Hip                    1.04     ±    0.115     1.119   ±   0.148   0.174   0.937   ±   0.096   0.96    ±   0.083   0.017
  Trochanter            0.859     ±     0.83     0.903   ±   0.11    0.020   0.741   ±   0.931   0.742   ±   0.826   0.002
  Inter-trochanter      1.166     ±    0.146     1.251   ±   0.185   0.290   1.055   ±   0.101   1.091   ±   0.087   0.063
  Femoral neck          0.946     ±     0.09     1.042   ±   0.166   0.713   0.867   ±   0.109   0.879   ±   0.119   0.027
  Lumbar spine          0.957     ±    0.136     1.057   ±   0.174   0.118   0.528   ±   0.113   0.923   ±   0.09    0.164
  Average arms          0.753     ±    0.894     0.776   ±   0.062   0.076   0.753   ±   0.18    0.74    ±   0.073     1
  Average legs          1.288     ±    0.151     1.377   ±   0.124   0.005   1.219   ±   0.112   1.243   ±   0.155   0.046
  Head                  1.953     ±    0.346     2.141   ±   0.301     1     1.788   ±   0.329   2.142   ±   0.363     1
  *vBMD (g cm^−3^)*                                                                                                 
  Femoral neck          0.346     ±    0.036     0.364   ±   0.068     1     0.334   ±   0.051   0.315   ±   0.036   0.171
  Lumbar spine           0.27     ±    0.022     0.28    ±   0.044   0.268   0.244   ±   0.027   0.271   ±   0.026     1
  BMAD                  0.091     ±    0.006     0.185   ±   0.265     1     0.092   ±   0.007   0.093   ±   0.005   0.551

Values as mean and SD. P values calculated with ANOVA.

\*P\<0.05 compared to control group ≥17 yr.

P\<0.05 compared to control group \<17 yr.

Bone mineral apparent density (BMAD).

10.1371/journal.pone.0024841.t007

###### Bone mineral area in control and cyclist group under 17 (\<17 yr) and equal or over (≥17 yr).

![](pone.0024841.t007){#pone-0024841-t007-7}

                      Controls       Cyclists                                                                              
  ------------------ ---------- --- ---------- --------- --- -------- ------- --------- --- -------- -------- --- -------- -------
  Whole body          2152.31    ±    314.47    2279.52   ±   176.06   0.117   1925.74   ±   147.61   2089.6   ±   203.38   0.418
  Pelvis               236.67    ±    50.27     264.45    ±   25.86      1     220.31    ±   26.73    243.09   ±   21.16      1
  Hip                  36.32     ±     6.09      41.52    ±    3.81      1      36.58    ±    3.53    40.156   ±    3.21      1
  Trochanter           11.08     ±     2.02      12.28    ±    1.46      1      10.7     ±    0.95    11.83    ±    1.17      1
  Inter-trochanter     19.98     ±     4.43      23.75    ±    2.94      1      20.87    ±    2.96    23.04    ±    2.26      1
  Femoral neck          5.26     ±     0.48      5.49     ±    0.39    0.742    5.01     ±    0.32     5.28    ±    0.39      1
  Lumbar spine         60.82     ±     9.42      68.35    ±    6.85      1      58.83    ±    5.46    62.124   ±    7.43    0.449
  Average arms         209.51    ±    42.75     227.37    ±   24.49    0.062   175.22    ±   22.28    211.01   ±   26.29      1
  Average legs         395.88    ±    57.38     410.09    ±   39.55    0.115   352.58    ±   30.76    366.03   ±   36.77    0.175
  Head                 238.28    ±    15.47     244.75    ±   11.93      1     231.13    ±   12.56    239.9    ±   14.91      1

Values as mean and SD. P values calculated with ANOVA.

P\<0.05 compared to control group ≥17 yr.

P\<0.05 compared to control group \< 17 yr.

Volumetric bone mineral density (vBMD); bone mineral apparent density (BMAD).

10.1371/journal.pone.0024841.t008

###### Adjusted Bone mineral content (BMC) in control and cyclists group under 17 (\<17 yr) and equal or over (≥17 yr).

![](pone.0024841.t008){#pone-0024841-t008-8}

                      Controls       Cyclists                                                                              
  ------------------ ---------- --- ---------- -------- --- ------ ------- -------- --- ------ -------- --- ------ ------- -------
  Whole body           2413.9    ±     51.7     2474.8   ±   64.5   0.781   2288.8   ±   59.9   2283.8   ±   54.8   0.171   0.565
  Pelvis               277.2     ±     9.5      310.9    ±   11.9     1     264.1    ±   11.0   245.7    ±   10.1   0.001   0.017
  Hip                   37.3     ±     1.1       42.1    ±   1.4      1      39.6    ±   1.3     38.1    ±   1.2    0.216   0.015
  Trochanter            9.4      ±     0.4       10.1    ±   0.5      1      9.3     ±   0.5     8.7     ±   0.4    0.214   0.123
  Inter-trochanter      23.1     ±     0.9       26.7    ±   1.1    0.515    25.5    ±   1.0     24.8    ±   1.0      1     0.033
  Femoral neck          4.9      ±     0.2       5.3     ±   0.2      1      4.8     ±   0.2     4.6     ±   0.2    0.055   0.084
  Lumbar spine          58.0     ±     2.6       65.3    ±   3.3      1      56.9    ±   3.1     56.7    ±   2.8    0.312   0.199
  Average arms         155.6     ±     4.2      154.6    ±   5.2      1     147.0    ±   4.8    156.8    ±   4.4      1     0.248
  Average legs         506.4     ±     11.0     503.7    ±   13.8   0.055   459.1    ±   12.8   440.5    ±   11.7   0.007   0.516
  Head                 458.8     ±     20.3     477.9    ±   25.4     1     468.8    ±   23.6   510.8    ±   21.6     1     0.611

Values as mean and SD. P values calculated with repeated measures ANCOVA adjusted with total lean mass and height.

\*P\<0.05 compared to control group ≥17 yr.

P\<0.05 compared to control group \<17 yr.

P\<0.05 interaction group × age.

10.1371/journal.pone.0024841.t009

###### Adjusted Bone mineral density (BMD) and volumetric density (vBMD) in control and cyclists group under 17 (\<17 yr) and equal or over (≥17 yr).

![](pone.0024841.t009){#pone-0024841-t009-9}

                       Controls       Cyclists                                                                              
  ------------------- ---------- --- ---------- ------- --- ------- ------- ------- --- ------- ------- --- ------- ------- -------
  Whole body            1.113     ±    0.025     1.164   ±   0.025     1     1.075   ±   0.023   1.099   ±   0.021   0.316   0.543
  Pelvis                1.151     ±    0.031     1.27    ±   0.039   0.489   1.063   ±   0.036   1.02    ±   0.033   0.001   0.023
  Hip                   1.016     ±    0.023     1.085   ±   0.029     1       1     ±   0.027   0.954   ±   0.024   0.008   0.03
  Trochanter            0.843     ±     0.21     0.874   ±   0.026   0.650   0.789   ±   0.024   0.737   ±   0.22    0.001   0.076
  Inter-trochanter      1.138     ±    0.029     1.216   ±   0.037     1     1.124   ±   0.034   1.085   ±   0.031   0.052   0.076
  Femoral neck          0.918     ±    0.025     1.009   ±   0.031     1     0.934   ±   0.029   0.874   ±   0.026   0.01    0.008
  Lumbar spine          0.928     ±    0.025     1.012   ±   0.032     1     0.906   ±   0.029   0.916   ±   0.027   0.148   0.191
  Average arms          0.743     ±    0.012     0.742   ±   0.015     1     0.725   ±   0.014   0.749   ±   0.013     1     0.356
  Average legs          1.269     ±    0.024     1.318   ±   0.03    0.182   1.186   ±   0.027   1.21    ±   0.025   0.045   0.633
  Head                  1.908     ±    0.077     2.012   ±   0.097     1     1.967   ±   0.09    2.123   ±   0.082     1     0.759
  *vBMD (g cm^−3^)*                                                                                                         
  Femoral neck          0.331     ±    0.009     0.369   ±   0.011     1     0.348   ±   0.01    0.315   ±   0.009   0.004   0.001
  Lumbar spine          0.263     ±    0.007     0.278   ±   0.009     1     0.255   ±   0.008   0.27    ±   0.007     1     0.992
  BMAD                  0.089     ±    0.035     0.186   ±   0.043     1     0.092   ±   0.04    0.093   ±   0.037   0.634   0.211

Values as mean and SD. P values calculated with repeated measures ANCOVA adjusted with total lean mass and height.

\*P\<0.05 compared to control group ≥17 yr.

P\<0.05 compared to control group \<17 yr.

P\<0.05 interaction group × age. Bone mineral apparent density (BMAD).

10.1371/journal.pone.0024841.t010

###### Adjusted Bone mineral area in control and cyclists group under 17 (\<17 yr) and equal or over (≥17 yr).

![](pone.0024841.t010){#pone-0024841-t010-10}

                      Controls       Cyclists                                                                                    
  ------------------ ---------- --- ---------- --------- --- ------- ------- --------- --- ------- --------- --- ------- ------- -------
  Whole body           2144.3    ±    20.37     2113.46   ±   25.42   0.695   2093.01   ±   23.59   2067.12   ±   21.58     1     0.543
  Pelvis               236.15    ±     5.23     241.71    ±   6.53      1      242.5    ±   6.06    240.12    ±   5.55      1     0.912
  Hip                  36.39     ±     0.68      38.55    ±   0.84    0.053    39.31    ±   0.78     39.78    ±   0.72      1     0.262
  Trochanter           11.03     ±     0.28      11.4     ±   0.35      1      11.59    ±   0.32     11.72    ±   0.29      1     0.695
  Inter-trochanter     20.03     ±     0.68      21.87    ±   0.84    0.123    22.59    ±   0.78     22.8     ±   0.72      1     0.282
  Femoral neck          5.32     ±     0.08      5.28     ±    0.1    0.797    5.13     ±    0.1     5.25     ±   0.09      1     0.357
  Lumbar spine         61.43     ±     1.48      63.97    ±   1.85      1      62.22    ±   1.71     61.59    ±   1.57      1     0.335
  Average arms         206.2     ±     4.28     207.67    ±   5.35      1     197.99    ±   4.96    208.28    ±   4.54      1     0.335
  Average legs         396.16    ±     6.16     380.55    ±   7.69    0.641   380.23    ±   7.14    362.23    ±   6.53    0.448   0.86
  Head                 238.99    ±     2.86     236.93    ±   3.58      1     237.65    ±   3.32    238.93    ±   3.04      1     0.599

Values as mean and SD. P values calculated with repeated measures ANCOVA adjusted with total lean mass and height.

\*P\<0.05 compared to control group ≥17 yr.

P\<0.05 compared to control group \<17 yr.

P\<0.05 interaction group × age.

Analyses were repeated including fat mass as covariable with no variation of the presented results.

Group interaction by age was found for BMC at the pelvis, hip and inter-trochanter sub-regions, and for BMD at the pelvis, hip and femoral neck (all P≤0.05, [Table 8](#pone-0024841-t008){ref-type="table"} & [9](#pone-0024841-t009){ref-type="table"}), as well as for vBMD at the femoral neck (P≤0.001, [Figure 1](#pone-0024841-g001){ref-type="fig"}).

![Group × age interaction for femoral neck volumetric bone mineral density (vBMD; P\<0.01) in young and old adolescent cyclists and controls.\
\* P\<0.05 between control and cyclists groups ≥17 years.](pone.0024841.g001){#pone-0024841-g001}

All the previous comparisons exhibited large effect sizes (Cohen\'s d ranged from 0.8 to 7), excepting the hip BMD which were low (Cohen\'s d = 0.3).

Discussion {#s4}
==========

The main finding herein is that adolescent cyclists had lower BMC and BMD compared with healthy age-matched controls in regions of clinical interest (hip, pelvis and femoral neck). Our study also shows that differences in BMC and BMD between cyclists and controls were higher in adolescents over 17 years old.

The present study shows that adolescent cyclists had lower BMC and BMD than healthy age-matched controls. Cross-sectional and longitudinal studies have shown that weight-bearing and impact-loading sports improve bone mass, especially at weight-bearing sites [@pone.0024841-Bassey1], [@pone.0024841-Dorado1], [@pone.0024841-VicenteRodriguez3]. However, athletes who perform activities in which the body weight load is diminished or without impacts, as in cycling, are associated with a lower bone mass compared with athletes who participated in weight-bearing sports [@pone.0024841-Morel1], [@pone.0024841-Nevill1]. Male professional cyclists had lower BMD for the whole body (12%), legs (16%), pelvis (18%), femoral neck (25%) [@pone.0024841-Bassey1] and lumbar spine [@pone.0024841-VicenteRodriguez4] than non-active controls of similar age.

The differences observed in BMC and BMD in our adolescent cyclists are similar to those observed previously in professional cyclists who trained 3 times as much [@pone.0024841-Bassey1]. Sanchis et al. [@pone.0024841-SanchisMoysi1] found that young tennis players had 69% of the inter-arm asymmetry in BMC observed in professional tennis players who trained nearly twice as much, and all the asymmetry in bone area. In the review literature, we have found only 3 studies evaluating the bone mass in adolescent cyclists [@pone.0024841-Nichols1], [@pone.0024841-Rico1], [@pone.0024841-Duncan2]. Rico et al. [@pone.0024841-Rico1] did not find differences in total or regional BMC between male adolescent cyclists with a similar training frequency than in the present study (10 h/week), and age-matched controls, when values were corrected by body weight; one possible explanation that may explain this discrepancy is that in our study we corrected the BMC and BMD by the total lean mass and the height, as they are the variables having the highest effect on bone growth [@pone.0024841-VicenteRodriguez1]. Unfortunately Rico et al. [@pone.0024841-Rico1] did not evaluate BMD.

Duncan at al. [@pone.0024841-Nichols1] observed that female cyclists had similar BMD at whole body, lumbar, femoral neck, legs and arms than non-active population, but lower BMD at whole body, femoral neck and legs than a group of female runners. The same researchers compared total and cortical vBMD at the femur bone in adolescent females from different sport disciplines (cyclists, triathletes, swimmers and runners) and a non-active control group of the same gender [@pone.0024841-Duncan2]. Duncan et al (2002) showed that BMC and vBMD in mid femur was similar in all groups, except for runners who showed higher BMD values and bone strength than cyclists [@pone.0024841-Duncan2]. Several aspects may cause the differences between this latter research and the present one, such as different control groups (sedentary vs. actives) [@pone.0024841-VicenteRodriguez4], differences in lean mass [@pone.0024841-VicenteRodriguez3], or the known gender dimorphism in the bone development [@pone.0024841-Nichols2].

Our results showed that differences in BMC and BMD between cyclists and active controls were greater in adolescents over 17 years old than in those under that age. We also found a negative association between age and BMC, and BMD, in the cyclists. Unfortunately we only can compare our results with longitudinal studies conducted in adults. Nichols et al. [@pone.0024841-Nichols2] described the tracked changes in BMD over a 7-year period in competitive male master cyclists and non-athletes. Their results showed that at the beginning of the study, cyclists had lower lumbar and hip BMD than the control group; interestingly at the end of the study master cyclists had lost more BMD than controls [@pone.0024841-Wilks1]. A previous study examined BMD over a one year season in amateur male cyclists and found 1--1.5% decrease in BMD at the proximal femur but no changes at the lumbar spine [@pone.0024841-Ducher1]. Nichols et al. [@pone.0024841-Rizzoli1] observed that master cyclists (\>50 yr) had lower total, lumbar and hip BMD than younger cyclists (mean 31 yr).

Bone mineral density is the main variable used to determine osteoporosis [@pone.0024841-Kanis1]. There is a close relationship between BMD and bone mechanical strength [@pone.0024841-Lauritzen1]. Our study shows that adolescent cyclists developed lower BMD than controls at relevant clinical sites. This could increase the risk of bone fractures and/or osteoporosis. However, in spite of lower levels of BMD at clinical sites, adult cyclists develop a higher cortical thickness which can also increase bone strength [@pone.0024841-Wilks1].

A recent study showed that master professional cyclists (\>50 yr) exhibited greater BMC and cortical area at the tibiae and radius which was associated with higher polar momentum of resistance [@pone.0024841-Wilks1]. Longitudinal studies should be conducted to corroborate this finding and to analyze whether this effect can be generalized to include other bones of greater clinical interest [@pone.0024841-Ducher1].

Some limitations should be recognized. One is the design, from which it cannot be concluded that the effect that is observed in older adolescents is due to the longer period (years) of practice of cycling rather than internal (i.e. genetic) or external (i.e. energy imbalance) factors. The absence of hormone and calcium intake data is another potential weakness of this study because this may affect bone acquisition; although it could explain the mechanisms behind these observations they should not change the found lower bone mass found in cyclists.

Nevertheless, the analysis of the interaction between bone mass, age and cycling training may indicate that the practice of cycling training is linked to the lower bone mass found in our adolescents. In the same line we have found a strong negative correlation, after taking into account the age, height, muscle mass and years of practice, between hours of practice and BMC and BMD in all the regions studied in older adolescent cyclists (r = −0.31 to r = −0.76) although none of them reached statistical significance, maybe because the low sample. Nonetheless, this hypothesis must be corroborated with longitudinal or intervention studies.

A strength of this study is that volumetric density was calculated: vBMD and BMAD have been proposed as a better reflection of the real bone density [@pone.0024841-Katzman1], [@pone.0024841-Bachrach1]. We detect no other study where these bone parameters were estimated in adolescent cyclists. In our study, we found a 17% lower vBMD at the femoral neck of the older cyclists compared to older controls, which may be associated with an important risk of fracture in this relevant clinical zone. The BMAD in the cyclist group was 100% lower than that in the controls in the older adolescents; although of no statistical significance, maybe because of the sample size, this may imply important biological consequences reflected by the high effect size.

Conclusions {#s4a}
-----------

Our study shows that cycling training, may adversely affect bone mass during adolescence. Although this is a case control study and caution must be used in interpreting the results, the practice of cycling practice during adolescence may compromise the acquisition of bone mass.
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